Question 430
A new supplier issue pushes residual risk scoring above the board-authorized limit. Which risk metric, treatment, or analysis MOST accurately applies?
Explanation
Correct Answer
An analyst should not silently accept it. Escalate the evidence and current rating to the accountable business risk owner or delegated governance body, request treatment or a formally authorized exception, and set an interim control plan. No operational analyst should silently accept a supplier exposure beyond approved limits. Escalate the supplier risk to its accountable owner or delegated committee, document the breached threshold and obtain an approved treatment decision.
Incorrect Answers
Technical mitigation may be part of an approved response after escalation, but operating teams should not unilaterally accept or choose the treatment for a supplier risk above board-authorized limits. Governance ownership determines the next decision. Installing safeguards may be one future treatment, but the immediate requirement is to escalate a residual score that already exceeds delegated authority.
Neglect is not acceptance. Documented acceptance can be permitted only within the assigned authority and the company's appetite. The stated residual score exceeds a board-authorized ceiling, so simple acceptance at a lower level violates the defined limit. No owner can accept the exposure merely as routine when its score is above the board-authorized limit; it must return for an authorized decision.
A risk register records the asset, event, likelihood, impact, owner, treatment and review timing. It supports traceability over time. A risk register should record the changed exposure and accountable owner, but creating a record alone does not authorize tolerance above the approved boundary. The threshold breach must be reported to the right decision maker.